AP
Aptorum Group
APM·NASDAQHong Kong CNFounded 201730 employees
Micro CapbiotechPublicInfectious Disease
Platform: ALS-4 GI
Market Cap
$0.02B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (APM)
Loading APM stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| APM-3452 | APM-3452 | Phase 1/2 | 1 | CD19 | EpilepsyOvarian Ca | ||
| APM-4255 | APM-4255 | NDA/BLA | 2 | CD123 | CeliacMyelofibrosis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)